Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Research Square
|
February 6, 2026
PTPN11-Related Noonan Syndrome Predisposes to Multifocal Low-Grade CNS Tumors Harboring FGFR1 Variants
Gary Kohanbash, Scott Ryall, Sam E Gary, et al.
Journal of Neuro-Oncology
|
March 5, 2026
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants
Gary Kohanbash, Scott Ryall, Sam E Gary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC
Hideho Okada, Lisa H Butterfield, Ronald L Hamilton, et al.
Molecular Cancer Therapeutics
|
July 10, 2025
Targeting tumor-infiltrating immune cells for targeted alpha therapy in gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b dosing through PET-imaging
Ambika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Molecular Cancer Therapeutics
|
July 23, 2025
Targeting Tumor-Infiltrating Immune Cells for Targeted Alpha Therapy in Gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b Dosing through PET Imaging
Ambika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
Itay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Journal of Neuroinflammation
|
December 9, 2025
Microbial production of short-chain fatty acids attenuates long-term neurologic impairment after traumatic brain injury
Zujian Xiong, Brittany P Dodson, Matthew B Rogers, et al.
Oncoimmunology
|
July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastoma
Tiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
Frontiers in Immunology
|
May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Molecular Cancer Therapeutics
|
February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors
Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Research Square
|
February 6, 2026
PTPN11-Related Noonan Syndrome Predisposes to Multifocal Low-Grade CNS Tumors Harboring FGFR1 Variants
Gary Kohanbash, Scott Ryall, Sam E Gary, et al.
Journal of Neuro-Oncology
|
March 5, 2026
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants
Gary Kohanbash, Scott Ryall, Sam E Gary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC
Hideho Okada, Lisa H Butterfield, Ronald L Hamilton, et al.
Molecular Cancer Therapeutics
|
July 10, 2025
Targeting tumor-infiltrating immune cells for targeted alpha therapy in gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b dosing through PET-imaging
Ambika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Molecular Cancer Therapeutics
|
July 23, 2025
Targeting Tumor-Infiltrating Immune Cells for Targeted Alpha Therapy in Gliomas: Optimization of [225Ac]Ac-DOTA-αCD11b Dosing through PET Imaging
Ambika P Jaswal, Anders Josefsson, Angel G Cortez, et al.
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection
Itay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Journal of Neuroinflammation
|
December 9, 2025
Microbial production of short-chain fatty acids attenuates long-term neurologic impairment after traumatic brain injury
Zujian Xiong, Brittany P Dodson, Matthew B Rogers, et al.
Oncoimmunology
|
July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastoma
Tiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
Frontiers in Immunology
|
May 24, 2021
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael, Rajeev Kumar, Lauren H McCarl, et al.
Molecular Cancer Therapeutics
|
February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors
Jeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Page
of 9